Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 5 Glioblastoma 4 Lung Neoplasms 3 Carcinoma, Hepatocellular 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Glioma 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pancreatic Cyst 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Mesothelioma 1 Medication Adherence 1 Margins of Excision 1 Lymphedema 1 Lung Diseases 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Early-stage Peripheral Non-small Cell Lung Cancer 1

Interventions

Nivolumab 143 pembrolizumab 129 Sunitinib 127 Bevacizumab 71 Everolimus 70 Sorafenib 68 cabozantinib 64 Ipilimumab 61 pazopanib 58 Axitinib 57 aldesleukin 51 Magnetic Resonance Spectroscopy 43 Cyclophosphamide 40 Interleukin-2 38 lenvatinib 36 Radiosurgery 36 Specimen Handling 33 Interferon-alpha 32 atezolizumab 29 belzutifan 24 temsirolimus 23 Gemcitabine 23 fludarabine phosphate 22 Radiotherapy 18 Interferon alpha-2 18 Biopsy 18 fludarabine 17 durvalumab 17 avelumab 17 Paclitaxel 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Renal Cell × Drug Delivery Systems × Clear all

NCT01967407 2014-11-19

IRENE

University of Magdeburg

Phase 1/2 Unknown

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡